Cargando…

Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis

Discovery of rare or low frequency variants in exome or genome data that are associated with complex traits often will require use of very large sample sizes to achieve adequate statistical power. For a fixed sample size, sequencing of individuals sampled from the tails of a phenotype distribution (...

Descripción completa

Detalles Bibliográficos
Autores principales: Emond, Mary J., Louie, Tin, Emerson, Julia, Chong, Jessica X., Mathias, Rasika A., Knowles, Michael R., Rieder, Mark J., Tabor, Holly K., Nickerson, Debbie A., Barnes, Kathleen C., GO, Lung, Gibson, Ronald L., Bamshad, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457883/
https://www.ncbi.nlm.nih.gov/pubmed/26047157
http://dx.doi.org/10.1371/journal.pgen.1005273
_version_ 1782375016013234176
author Emond, Mary J.
Louie, Tin
Emerson, Julia
Chong, Jessica X.
Mathias, Rasika A.
Knowles, Michael R.
Rieder, Mark J.
Tabor, Holly K.
Nickerson, Debbie A.
Barnes, Kathleen C.
GO, Lung
Gibson, Ronald L.
Bamshad, Michael J.
author_facet Emond, Mary J.
Louie, Tin
Emerson, Julia
Chong, Jessica X.
Mathias, Rasika A.
Knowles, Michael R.
Rieder, Mark J.
Tabor, Holly K.
Nickerson, Debbie A.
Barnes, Kathleen C.
GO, Lung
Gibson, Ronald L.
Bamshad, Michael J.
author_sort Emond, Mary J.
collection PubMed
description Discovery of rare or low frequency variants in exome or genome data that are associated with complex traits often will require use of very large sample sizes to achieve adequate statistical power. For a fixed sample size, sequencing of individuals sampled from the tails of a phenotype distribution (i.e., extreme phenotypes design) maximizes power and this approach was recently validated empirically with the discovery of variants in DCTN4 that influence the natural history of P. aeruginosa airway infection in persons with cystic fibrosis (CF; MIM219700). The increasing availability of large exome/genome sequence datasets that serve as proxies for population-based controls affords the opportunity to test an alternative, potentially more powerful and generalizable strategy, in which the frequency of rare variants in a single extreme phenotypic group is compared to a control group (i.e., extreme phenotype vs. control population design). As proof-of-principle, we applied this approach to search for variants associated with risk for age-of-onset of chronic P. aeruginosa airway infection among individuals with CF and identified variants in CAV2 and TMC6 that were significantly associated with group status. These results were validated using a large, prospective, longitudinal CF cohort and confirmed a significant association of a variant in CAV2 with increased age-of-onset of P. aeruginosa airway infection (hazard ratio = 0.48, 95% CI=[0.32, 0.88]) and variants in TMC6 with diminished age-of-onset of P. aeruginosa airway infection (HR = 5.4, 95% CI=[2.2, 13.5]) A strong interaction between CAV2 and TMC6 variants was observed (HR=12.1, 95% CI=[3.8, 39]) for children with the deleterious TMC6 variant and without the CAV2 protective variant. Neither gene showed a significant association using an extreme phenotypes design, and conditions for which the power of an extreme phenotype vs. control population design was greater than that for the extreme phenotypes design were explored.
format Online
Article
Text
id pubmed-4457883
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44578832015-06-09 Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis Emond, Mary J. Louie, Tin Emerson, Julia Chong, Jessica X. Mathias, Rasika A. Knowles, Michael R. Rieder, Mark J. Tabor, Holly K. Nickerson, Debbie A. Barnes, Kathleen C. GO, Lung Gibson, Ronald L. Bamshad, Michael J. PLoS Genet Research Article Discovery of rare or low frequency variants in exome or genome data that are associated with complex traits often will require use of very large sample sizes to achieve adequate statistical power. For a fixed sample size, sequencing of individuals sampled from the tails of a phenotype distribution (i.e., extreme phenotypes design) maximizes power and this approach was recently validated empirically with the discovery of variants in DCTN4 that influence the natural history of P. aeruginosa airway infection in persons with cystic fibrosis (CF; MIM219700). The increasing availability of large exome/genome sequence datasets that serve as proxies for population-based controls affords the opportunity to test an alternative, potentially more powerful and generalizable strategy, in which the frequency of rare variants in a single extreme phenotypic group is compared to a control group (i.e., extreme phenotype vs. control population design). As proof-of-principle, we applied this approach to search for variants associated with risk for age-of-onset of chronic P. aeruginosa airway infection among individuals with CF and identified variants in CAV2 and TMC6 that were significantly associated with group status. These results were validated using a large, prospective, longitudinal CF cohort and confirmed a significant association of a variant in CAV2 with increased age-of-onset of P. aeruginosa airway infection (hazard ratio = 0.48, 95% CI=[0.32, 0.88]) and variants in TMC6 with diminished age-of-onset of P. aeruginosa airway infection (HR = 5.4, 95% CI=[2.2, 13.5]) A strong interaction between CAV2 and TMC6 variants was observed (HR=12.1, 95% CI=[3.8, 39]) for children with the deleterious TMC6 variant and without the CAV2 protective variant. Neither gene showed a significant association using an extreme phenotypes design, and conditions for which the power of an extreme phenotype vs. control population design was greater than that for the extreme phenotypes design were explored. Public Library of Science 2015-06-05 /pmc/articles/PMC4457883/ /pubmed/26047157 http://dx.doi.org/10.1371/journal.pgen.1005273 Text en © 2015 Emond et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Emond, Mary J.
Louie, Tin
Emerson, Julia
Chong, Jessica X.
Mathias, Rasika A.
Knowles, Michael R.
Rieder, Mark J.
Tabor, Holly K.
Nickerson, Debbie A.
Barnes, Kathleen C.
GO, Lung
Gibson, Ronald L.
Bamshad, Michael J.
Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis
title Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis
title_full Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis
title_fullStr Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis
title_full_unstemmed Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis
title_short Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis
title_sort exome sequencing of phenotypic extremes identifies cav2 and tmc6 as interacting modifiers of chronic pseudomonas aeruginosa infection in cystic fibrosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457883/
https://www.ncbi.nlm.nih.gov/pubmed/26047157
http://dx.doi.org/10.1371/journal.pgen.1005273
work_keys_str_mv AT emondmaryj exomesequencingofphenotypicextremesidentifiescav2andtmc6asinteractingmodifiersofchronicpseudomonasaeruginosainfectionincysticfibrosis
AT louietin exomesequencingofphenotypicextremesidentifiescav2andtmc6asinteractingmodifiersofchronicpseudomonasaeruginosainfectionincysticfibrosis
AT emersonjulia exomesequencingofphenotypicextremesidentifiescav2andtmc6asinteractingmodifiersofchronicpseudomonasaeruginosainfectionincysticfibrosis
AT chongjessicax exomesequencingofphenotypicextremesidentifiescav2andtmc6asinteractingmodifiersofchronicpseudomonasaeruginosainfectionincysticfibrosis
AT mathiasrasikaa exomesequencingofphenotypicextremesidentifiescav2andtmc6asinteractingmodifiersofchronicpseudomonasaeruginosainfectionincysticfibrosis
AT knowlesmichaelr exomesequencingofphenotypicextremesidentifiescav2andtmc6asinteractingmodifiersofchronicpseudomonasaeruginosainfectionincysticfibrosis
AT riedermarkj exomesequencingofphenotypicextremesidentifiescav2andtmc6asinteractingmodifiersofchronicpseudomonasaeruginosainfectionincysticfibrosis
AT taborhollyk exomesequencingofphenotypicextremesidentifiescav2andtmc6asinteractingmodifiersofchronicpseudomonasaeruginosainfectionincysticfibrosis
AT nickersondebbiea exomesequencingofphenotypicextremesidentifiescav2andtmc6asinteractingmodifiersofchronicpseudomonasaeruginosainfectionincysticfibrosis
AT barneskathleenc exomesequencingofphenotypicextremesidentifiescav2andtmc6asinteractingmodifiersofchronicpseudomonasaeruginosainfectionincysticfibrosis
AT exomesequencingofphenotypicextremesidentifiescav2andtmc6asinteractingmodifiersofchronicpseudomonasaeruginosainfectionincysticfibrosis
AT golung exomesequencingofphenotypicextremesidentifiescav2andtmc6asinteractingmodifiersofchronicpseudomonasaeruginosainfectionincysticfibrosis
AT gibsonronaldl exomesequencingofphenotypicextremesidentifiescav2andtmc6asinteractingmodifiersofchronicpseudomonasaeruginosainfectionincysticfibrosis
AT bamshadmichaelj exomesequencingofphenotypicextremesidentifiescav2andtmc6asinteractingmodifiersofchronicpseudomonasaeruginosainfectionincysticfibrosis